KRAS and Familial prostate cancer: In 2013, Ling showed that the over-expression of miR-30c repressed the cell proliferation, invasion and metastasis abilities of prostate cancer via blocking the KRAS-MAPK pathway, meanwhile, the down-regulated expression level of miR-30c predicts the early biochemical recurrence and worse prognosis of prostate cancer patients60.